Tilray | TRLY - 贷款资金

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 5.63B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	贷款资金	更改		日
Acasti Pharma	USD 0		0	2024-12
Akebia Therapeutics	USD 36.39M		11.85M	2026-03
Alaunos Therapeutics	USD 4.47M		5.85M	2022-06
Aurora Cannabis	CAD 33.2M		1.79M	2025-12
Avita Medical	AUD 42.24M		1.25M	2024-12
Canopy Growth	CAD 224.99M		1.34M	2025-12
Dianthus Therapeutics	USD 0		0	2024-12
Divis Laboratories Ltd	INR 20M		0	2025-03
Ionis Pharmaceuticals	USD 1.91B		9M	2026-03
IQVIA Holdings	USD 13.99B		105M	2026-03
Knight Therapeutics	CAD 57.78M		26.92M	2025-12
Moderna	USD 603M		7M	2026-03
Organigram Holdings	CAD 62.52M		13.88M	2025-12
Organon & Co	USD 8.55B		75M	2026-03
Revvity	USD 2.63B		836K	2026-03
Tectonic Therapeutic	USD 43K		57K	2025-12
Tilray	USD 268.59M		3.82M	2025-09
Viatris	USD 12.41B		67.1M	2026-03
Xeris Pharmaceuticals	USD 221.22M		889K	2026-03
Zealand Pharma A/S	383.14M		727K	2025-12